Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and ...
In early January 2026, Moderna filed for marketing authorization of its investigational seasonal influenza vaccine mRNA-1010 ...
Kramer was the CEO of Emergent BioSolutions, a government contractor hired to mass produce coronavirus vaccine doses, 400 ...
Hindustan Times on November 28, 2025, published the report of alleged tetanus injection shortage at the civic hospital ...
The US dramatically altered its recommendations for a series of vaccines, which drive billion-dollar earnings for giants like ...
Robert G. Kramer sold nearly 90,000 shares of his stock in Emergent BioSolutions, knowing that large quantities of vaccine ...
Vaccine makers saw their shares fall Monday on the New York Stock Exchange following the leak of a document attributed to a senior US official calling for a major overhaul of the country's ...
The COVID-19 Vaccine Decision Aid is available for download at aafa.org/covid or directly via this link: https://aafa.org/wp-content/uploads/2026/01/covid-19-vaccine-decision-aid.pdf . People can ...
In 2025, Fundsmith Equity Fund began building a position in Zoetis, while the company reported third-quarter revenue growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback